EUVIMEDEUVIMED entdecken
Crossref

A Clinical Comparative Study of Effects of Ropivacaine and Ropivacaine with Dexmedetomidine as an Adjuvant in Ultrasound Guided Axillary Brachial Plexus Block in Forearm and Hand Surgeries

Yogesh Kumar Manik, Ravi Kumar Agrawal, Anjali Dixit, Sarika Gupta

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Yogesh Kumar Manik und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For forearm and hand surgeries, ultrasound-guided axillary brachial plexus block (USG-ABPB) is routinely used for its effective intra-operative anaesthesia and prolonged post-operative analgesia. Dexmedetomidine (DEX) (α2-adrenergic agonist) is used as an adjuvant to local anesthetics to improve block characteristics and for prolonged analgesia. The present study compared ropivacaine alone with ropivacaine plus DEX as an adjuvant in USG-ABPB for forearm and hand surgeries.

Methods

Sixty patients were studied in a prospective, randomized, comparative study posted for elective forearm and hand surgeries. Two groups were formed: Group A (received ropivacaine) and Group B (received ropivacaine with DEX). Characteristics of sensory and motor block, duration of postoperative analgesia, hemodynamic parameters, and complications were recorded.

Results

The onset of sensory block was faster in Group B (8.23 ± 1.07 min vs. 12.50 ± 1.28 min; p < 0.001). The onset of motor block was earlier in Group B (10.87 ± 1.07 min vs. 15.60 ± 1.67 min; p < 0.001). Duration of sensory block (545.33 ± 27.76 min vs. 401.67 ± 31.19 min; p < 0.001), motor block (517.00 ± 17.65 min vs. 391.00 ± 37.54 min; p < 0.001), and postoperative analgesia (606.67 ± 18.63 min vs. 462.00 ± 40.38 min; p < 0.001) were significantly prolonged in Group B.

Conclusion

Dexmedetomidine is an effective and safe adjunct to ropivacaine in USG-ABPB.

Zitieren

APA

Manik, Y. K., Agrawal, R. K., Dixit, A., & Gupta, S. (2026). A Clinical Comparative Study of Effects of Ropivacaine and Ropivacaine with Dexmedetomidine as an Adjuvant in Ultrasound Guided Axillary Brachial Plexus Block in Forearm and Hand Surgeries. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.273

Vancouver

Manik YK, Agrawal RK, Dixit A, Gupta S. A Clinical Comparative Study of Effects of Ropivacaine and Ropivacaine with Dexmedetomidine as an Adjuvant in Ultrasound Guided Axillary Brachial Plexus Block in Forearm and Hand Surgeries. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.273

BibTeX
@article{Manik2026,
  author = {Manik, Yogesh Kumar and Agrawal, Ravi Kumar and Dixit, Anjali and Gupta, Sarika},
  title = {A Clinical Comparative Study of Effects of Ropivacaine and Ropivacaine with Dexmedetomidine as an Adjuvant in Ultrasound Guided Axillary Brachial Plexus Block in Forearm and Hand Surgeries},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.273}
}
Kostenlos starten →